JPWO2022050423A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022050423A5
JPWO2022050423A5 JP2022547007A JP2022547007A JPWO2022050423A5 JP WO2022050423 A5 JPWO2022050423 A5 JP WO2022050423A5 JP 2022547007 A JP2022547007 A JP 2022547007A JP 2022547007 A JP2022547007 A JP 2022547007A JP WO2022050423 A5 JPWO2022050423 A5 JP WO2022050423A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
set forth
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022547007A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022050423A1 (https=
JP7505806B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/032827 external-priority patent/WO2022050423A1/ja
Publication of JPWO2022050423A1 publication Critical patent/JPWO2022050423A1/ja
Publication of JPWO2022050423A5 publication Critical patent/JPWO2022050423A5/ja
Application granted granted Critical
Publication of JP7505806B2 publication Critical patent/JP7505806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022547007A 2020-09-07 2021-09-07 スタビロン改変体に結合する抗体又はその抗原結合フラグメント Active JP7505806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020150003 2020-09-07
JP2020150003 2020-09-07
PCT/JP2021/032827 WO2022050423A1 (ja) 2020-09-07 2021-09-07 スタビロン改変体に結合する抗体又はその抗原結合フラグメント

Publications (3)

Publication Number Publication Date
JPWO2022050423A1 JPWO2022050423A1 (https=) 2022-03-10
JPWO2022050423A5 true JPWO2022050423A5 (https=) 2023-07-05
JP7505806B2 JP7505806B2 (ja) 2024-06-25

Family

ID=80491150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022547007A Active JP7505806B2 (ja) 2020-09-07 2021-09-07 スタビロン改変体に結合する抗体又はその抗原結合フラグメント

Country Status (2)

Country Link
JP (1) JP7505806B2 (https=)
WO (1) WO2022050423A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5961380B2 (ja) * 2009-05-20 2016-08-02 学校法人日本大学 ペプチド、融合タンパク質、核酸、発現ベクター、形質転換体、医薬組成物、抗体タンパク質
CN101888687A (zh) 2010-04-30 2010-11-17 中兴通讯股份有限公司 一种实现多频终端频段切换的方法及装置
JP6646310B2 (ja) * 2015-05-08 2020-02-14 学校法人日本大学 標識ペプチドおよびその使用

Similar Documents

Publication Publication Date Title
JP2022512234A5 (https=)
RU2018146050A (ru) Биспецифические связывающие белки, которые связывают иммуномодулирующий белок и опухолевый антиген
AR040046A1 (es) Anticuerpo neutralizante humano anti-igfr
HRP20190932T1 (hr) Molekule protutijela koje se vežu na il-17a i il-17f
JP2021520832A5 (https=)
JP2020510659A5 (https=)
FI3328893T3 (fi) Mesoteliinia ja cd3:a sitovia bispesifisiä vasta-ainekonstrukteja
JP2010502183A5 (https=)
RU2012147286A (ru) Гуманизированные антитела к фактору d и их применения
JP2023134618A5 (https=)
JP2010531145A5 (https=)
JP2003527861A5 (https=)
JP2017504578A5 (https=)
HRP20241013T1 (hr) Protutijela za kelatirane radionuklide
JP2010536384A5 (https=)
JP2025032102A5 (https=)
CR20240482A (es) Anticuerpos anti-tl1a y métodos de uso de los mismos
JP2010524435A5 (https=)
IL279901B1 (en) Antibodies comprising a polypeptide inserted in framework 3 region
JP2026004299A5 (https=)
JP2023520969A5 (https=)
JP2023549555A5 (https=)
WO2006050949A3 (de) Superagonistische anti-cd28 antikörper
JP2022501065A5 (https=)
JP2021519319A5 (https=)